comparemela.com
Home
Live Updates
OUtMATCH: Omalizumab Proves Utility in Multiple Food Allergies for Pediatric, Adult Patients : comparemela.com
OUtMATCH: Omalizumab Proves Utility in Multiple Food Allergies for Pediatric, Adult Patients
Omalizumab, the only FDA-approved treatment for multiple food allergies, demonstrated significant efficacy in the OUtMATCH trial, with 67% achieving the primary outcome compared to 7% in the placebo group.
Related Keywords
United States
,
American
,
Campbellp Robert Wood
,
R Sharon Chinthrajah
,
Sharon Chinthrajah
,
Omalizumab Xolair
,
American Academy Of Allergy
,
Asthma Research
,
Seann Parker Center
,
Stanford Medicine
,
Adjunct Therapy
,
Food Allergic Children
,
Pediatric Food
,
Multiple Food
,
Stanford Medicine Led
,
Aaaai 2024
,
Omalizumab
,
Outmatch Trial
,
Omalizumab And Outmatch Trial
,
Food Allergies
,
Pediatric Food Allergies
,
Food Allergy Management
,
comparemela.com © 2020. All Rights Reserved.